Bennaceur-Griscelli A - Search Results

1

Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML).

Desterke C, Voldoire M, Bonnet ML, Sorel N, Pagliaro S, Rahban H, Bennaceur-Griscelli A, Cayssials E, Chomel JC, Turhan AG. Desterke C, et al. Exp Hematol. 2018 Aug;64:71-83.e8. doi: 10.1016/j.exphem.2018.04.007. Epub 2018 May 5. Exp Hematol. 2018. PMID: 29733872 Free article.

2

Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model.

M'kacher R, Farace F, Bennaceur-Griscelli A, Violot D, Clausse B, Dossou J, Valent A, Parmentier C, Ribrag V, Bosq J, Carde P, Turhan AG, Bernheim A. M'kacher R, et al. Cancer Genet Cytogenet. 2003 May;143(1):32-8. doi: 10.1016/s0165-4608(02)00823-3. Cancer Genet Cytogenet. 2003. PMID: 12742154

3

High level of glutathione-S-transferase pi expression in mantle cell lymphomas.

Bennaceur-Griscelli A, Bosq J, Koscielny S, Lefrère F, Turhan A, Brousse N, Hermine O, Ribrag V. Bennaceur-Griscelli A, et al. Clin Cancer Res. 2004 May 1;10(9):3029-34. doi: 10.1158/1078-0432.ccr-03-0554. Clin Cancer Res. 2004. PMID: 15131039

4

A cross-talk between stromal cell-derived factor-1 and transforming growth factor-beta controls the quiescence/cycling switch of CD34(+) progenitors through FoxO3 and mammalian target of rapamycin.

Chabanon A, Desterke C, Rodenburger E, Clay D, Guerton B, Boutin L, Bennaceur-Griscelli A, Pierre-Louis O, Uzan G, Abecassis L, Bourgeade MF, Lataillade JJ, Le Bousse-Kerdilès MC. Chabanon A, et al. Stem Cells. 2008 Dec;26(12):3150-61. doi: 10.1634/stemcells.2008-0219. Epub 2008 Aug 28. Stem Cells. 2008. PMID: 18757300

5

Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.

Pierre-Louis O, Clay D, Brunet de la Grange P, Blazsek I, Desterke C, Guerton B, Blondeau C, Malfuson JV, Prat M, Bennaceur-Griscelli A, Lataillade JJ, Le Bousse-Kerdilès MC. Pierre-Louis O, et al. Stem Cells. 2009 Oct;27(10):2552-62. doi: 10.1002/stem.186. Stem Cells. 2009. PMID: 19650038

6

Toxicity and phototoxicity of Hypocrellin A on malignant human cell lines, evidence of a synergistic action of photodynamic therapy with Imatinib mesylate.

Chio-Srichan S, Oudrhiri N, Bennaceur-Griscelli A, Turhan AG, Dumas P, Refregiers M. Chio-Srichan S, et al. J Photochem Photobiol B. 2010 May 3;99(2):100-4. doi: 10.1016/j.jphotobiol.2010.03.001. Epub 2010 Mar 6. J Photochem Photobiol B. 2010. PMID: 20347325

7

Partial reversal of the methylation pattern of the X-linked gene HUMARA during hematopoietic differentiation of human embryonic stem cells.

Mitjavila-Garcia MT, Bonnet ML, Yates F, Haddad R, Oudrhiri N, Féraud O, Magniez A, Makhlouf M, Vallot C, Rougeulle C, Bennaceur-Griscelli A, Turhan AG. Mitjavila-Garcia MT, et al. J Mol Cell Biol. 2010 Oct;2(5):291-8. doi: 10.1093/jmcb/mjq026. Epub 2010 Sep 7. J Mol Cell Biol. 2010. PMID: 20823083

8

FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis.

Desterke C, Bilhou-Nabéra C, Guerton B, Martinaud C, Tonetti C, Clay D, Guglielmelli P, Vannucchi A, Bordessoule D, Hasselbalch H, Dupriez B, Benzoubir N, Bourgeade MF, Pierre-Louis O, Lazar V, Vainchenker W, Bennaceur-Griscelli A, Gisslinger H, Giraudier S, Le Bousse-Kerdilès MC; French Intergroup of Myeloproliferative Disorders,; French INSERM; European EUMNET Networks on Myelofibrosis. Desterke C, et al. Cancer Res. 2011 Apr 15;71(8):2901-15. doi: 10.1158/0008-5472.CAN-10-1731. Epub 2011 Apr 12. Cancer Res. 2011. PMID: 21487043

9

Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease.

Chomel JC, Bonnet ML, Sorel N, Bertrand A, Meunier MC, Fichelson S, Melkus M, Bennaceur-Griscelli A, Guilhot F, Turhan AG. Chomel JC, et al. Blood. 2011 Sep 29;118(13):3657-60. doi: 10.1182/blood-2011-02-335497. Epub 2011 Jul 25. Blood. 2011. PMID: 21791426 Free PMC article.

10

Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.

Griscelli F, Féraud O, Oudrhiri N, Gobbo E, Casal I, Chomel JC, Biéche I, Duvillard P, Opolon P, Turhan AG, Bennaceur-Griscelli A. Griscelli F, et al. Am J Pathol. 2012 May;180(5):2084-96. doi: 10.1016/j.ajpath.2012.01.011. Epub 2012 Mar 13. Am J Pathol. 2012. PMID: 22425713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters